Pendal Group’s Cardinal Health CAH Stock Holding History

Pendal Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$615K	Buy	+7,995	New	+$607K	0.01%	347
2022 Q3	–	Sell	-11,422	Closed	-$597K	–	462
2022 Q2	$597K	Sell	11,422 -18,531	-62%	-$1.05M	0.01%	326
2022 Q1	$1.7M	Hold	29,953	–	–	0.01%	277
2021 Q4	$1.54M	Buy	29,953 +12,699	+74%	+$623K	0.01%	287
2021 Q3	$853K	Sell	17,254 -92,744	-84%	-$5.03M	0.01%	344
2021 Q2	$6.28M	Sell	109,998 -8,679	-7%	-$507K	0.06%	123
2021 Q1	$7.21M	Buy	118,677 +11,757	+11%	+$649K	0.07%	115
2020 Q4	$5.73M	Buy	106,920 +32,099	+43%	+$1.67M	0.06%	108
2020 Q3	$3.51M	Sell	74,821 -18,356	-20%	-$942K	0.04%	123
2020 Q2	$4.86M	Buy	93,177 +79,684	+591%	+$4.11M	0.07%	107
2020 Q1	$647K	Buy	+13,493	New	+$701K	0.01%	249
2019 Q4	–	Sell	-1,482	Closed	-$69.9K	–	451
2019 Q3	$69.9K	Buy	+1,482	New	+$67.7K	﹤0.01%	440
2019 Q2	–	Sell	-116,093	Closed	-$4.63M	–	433
2019 Q1	$4.63M	Hold	116,093	–	–	0.06%	143
2018 Q4	$4.29M	Buy	+116,093	New	+$6.05M	0.07%	142

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Pendal Group's CAH Position: Q4 2022 in Review

Pendal Group opened a new position in Cardinal Health (CAH) in Q4 2022: 7,995 shares worth $615K. The stake represents 0.01% of the portfolio and ranks #347 among its holdings. This is a return to the name: Pendal Group previously reported a position in CAH as recently as Q2 2022.

Pendal Group first reported a position in CAH in Q4 2018 and has held it in 14 quarters since. The position peaked at $7.21M in Q1 2021. 930 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

Pendal Group held 7,995 shares of Cardinal Health worth $615K as of Q4 2022.
Cardinal Health was a new Pendal Group position in Q4 2022.
Cardinal Health made up 0.01% of Pendal Group's portfolio in Q4 2022, its #347 holding.
Pendal Group first reported a position in Cardinal Health in Q4 2018 and has held it in 14 quarters since.
Pendal Group's Cardinal Health position peaked at $7.21M in Q1 2021.
930 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.